Insulin Resistance in Atopic Dermatitis Patients
NCT05904509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2024-02-13
Summary
The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis.
Conditions
Sponsors & Collaborators
-
Bezmialem Vakif University
lead OTHER
Eligibility
- Min Age
- 2 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2023-10-01
- Completion
- 2023-10-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
NCT02002208 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis
NCT03912259 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)
NCT02564055 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT05999799 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis
NCT04212169 ·Status: COMPLETED ·Phase: PHASE2
-
KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
NCT05454462 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis
NCT02595008 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for HSK44459 in Participants With Atopic Dermatitis
NCT06996912 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dupilumab in Severe Chronic Hand Eczema
NCT04512339 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)
NCT03345914 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis
NCT04162899 ·Status: COMPLETED ·Phase: PHASE2
-
China Atopic Dermatitis Registry Study
NCT05023668 ·Status: UNKNOWN
-
Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis
NCT05916365 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.
NCT04836858 ·Status: COMPLETED ·Phase: PHASE2
-
MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement
NCT06455891 ·Status: COMPLETED
-
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
NCT03293030 ·Status: COMPLETED ·Phase: PHASE4
-
IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis
NCT05372003 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
NCT05098821 ·Status: RECRUITING
-
Prednisolone vs. Ciclosporine in Severe Atopic Eczema
NCT00445081 ·Status: COMPLETED ·Phase: PHASE4
-
Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
NCT03361215 ·Status: RECRUITING
-
Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China
NCT05624112 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Dupilumab on Allergic Contact Dermatitis
NCT03935971 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803 ·Status: RECRUITING
-
Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.
NCT05575882 ·Status: RECRUITING ·Phase: NA
-
Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
NCT05590585 ·Status: COMPLETED ·Phase: PHASE4